Changing diabetes medications isn't something you should take lightly. In some cases, you may need to do so because drug side effects are intolerable or the drugs are unable to control your blood ...

1, 2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts ... Mar. 27, 2025 — A research team ...

Trusted, comprehensive information and resources for your diabetes journey.

She held her normal levels without medication for over three months. She continued her drill, never dropping guard on diet and exercise, monitoring her blood sugar daily and following up regularly.

The main types of diabetes are type 1 ... If necessary, you may also need to take medication to manage cholesterol, high blood pressure, or other complications. T2D can be managed and sometimes ...

AZ is building a metabolic and cardiovascular franchise around Farxiga, which was first approved in type 2 diabetes and was added to the company’s portfolio of drugs after the company bought out ...

including AstraZeneca’s Farxiga and Janssen's Invokana. Most notable is Eli Lilly/Boehringer’s Jardiance, which has broken new ground by being the first diabetes drug licensed to claim a ...

Diabetes strikes 42 million in Canada and the US, can cannabis make a difference? The loss of Gossip Girl start Michelle Tractenberg has put diabetes in the national attention, Tractenberg ...

In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Among adults with thyroid cancer, those with hypoparathyroidism after a thyroidectomy may have increased risk for several complications such as diabetes, hypertension and dyslipidemia, researchers ...

The price of GLP-1 RAs tends to be high compared with other medications for treating type 2 diabetes. Is it safe to combine a GLP-1 RA with other medication? GLP-1 RAs are often prescribed in ...